The new joint ingredients: what the evidence actually says

1. UC-II® — undenatured type II collagen

UC-II® is collagen kept in its native three-dimensional shape rather than broken into peptides. That is the point: the proposed mechanism is not supplying raw material to cartilage but acting on the immune response through the gut, which is why it works at tiny doses.

Its canine record leads this group on two counts. In a 120-day controlled trial, dogs given UC-II® improved more on pain and lameness than dogs given 2,000 mg of glucosamine plus 1,600 mg of chondroitin — a head-to-head win against the incumbent, which nothing else here can claim. It has since been compared against a prescription anti-inflammatory, and a 2024 randomised, placebo-controlled crossover trial tested it with Boswellia serrata.

The second count is the one nobody markets: the effective dose is around 40 mg a day, which fits in a soft chew with room to spare. Most failures in this category are dose failures, not ingredient failures.

Honest limitation: the individual trials are small, a few dozen dogs each. UC-II®'s advantage is not trial size but that several independent trials point the same way, at a deliverable dose, against active comparators.

2. Eggshell membrane

The membrane inside an eggshell is a natural matrix of collagen, glycosaminoglycans and structural proteins — an intact matrix rather than an isolated molecule, which is a plausible answer to the absorption problem that sinks glucosamine.

It has one good canine trial: 51 dogs across eight clinics, randomised, double-blind, placebo-controlled, 13.5 mg/kg daily for six weeks. Pain and function improved from week one and held. More persuasively, serum CTX-II — a cartilage-breakdown biomarker — improved 47.9% against placebo, harder to dismiss as owner optimism than a questionnaire.

Verdict: promising, and clearly a better bet than glucosamine — but one solid trial is not several, and it has never been tested head-to-head either. We would rather see it replace glucosamine than be sprinkled on top.

3. Green-lipped mussel

Green-lipped mussel has positive, placebo-controlled canine trials, including a 45-dog randomised double-blind study and earlier work in The Journal of Nutrition. That is a genuine file and we are not going to pretend otherwise.

It still sits below UC-II®, and on evidence rather than preference. No trial has put green-lipped mussel head-to-head against glucosamine-chondroitin, so nothing shows it beats the ingredient it is sold to replace — UC-II® has that result, and it is the single most useful thing you can know about an alternative. Nor has it been compared against a prescription anti-inflammatory. The levels of evidence are simply not the same.

Then there is mechanism and dose. Its activity appears to come largely from its omega-3 lipid fraction — EPA, DHA and eicosatetraenoic acid — working the same pathways as fish oil: real, but not unique to the mussel. And the trials used grams of mussel powder, while supplements on the shelf typically carry 50 to 150 mg.

Verdict: real, but replaceable. It works at the dose the studies used — check the label against that, and if the answer is a hundred milligrams, a properly dosed fish oil does the same job for less.

4. CBD and hemp extracts

There is more here than sceptics expect. A randomised, placebo-controlled, blinded crossover trial at Cornell gave osteoarthritic dogs 2 mg/kg of CBD oil twice daily and reported reduced pain and improved activity; a 2023 systematic review has since pooled the canine studies.

Three caveats keep it off the top spots. The effect is analgesic, not structural — how the joint feels, not what it is doing. Product quality varies enormously, with independent testing repeatedly finding labelled content wrong in both directions. And the regulatory position for animal products is unsettled. Verdict: a legitimate comfort tool in a diagnosed, vet-supervised case — not a joint-structure ingredient, and not one to buy on a label alone.

5. Ursolic acid

Found in apple peel and various herbs, ursolic acid has an interesting laboratory profile around inflammation and muscle metabolism, and has started appearing in joint and longevity formulas on the strength of it. We could not find published clinical trials in dogs with osteoarthritis — not weak ones, none. The case rests on cell and rodent work, which is where every failed ingredient also looked good; glucosamine had a beautiful mechanistic story too.

Verdict: too early. No canine evidence, and no way for you to check a claim about it.

How to use this list

Read the first three ingredients on any joint supplement and ask three things: does it have controlled trials in dogs, has it ever beaten the ingredient it replaces, and is the amount here near what those trials used? Glucosamine fails the first. Green-lipped mussel passes the first and usually fails the third. UC-II® is the only one here that passes all three — which is why it keeps ending up at the top of our grading.

This article is general information, not veterinary advice. Ingredient doses and formulations change — always read the current label, and talk to your own veterinarian before starting anything, particularly if your dog is on medication.